ScitoVation logo
  • Services
    • Common Problems We Solve
      • Screening and Assessing Lead Compounds
      • Understanding the Mode of Action of a Compound
      • Predicting Equivalent Dose in Humans
    • Technologies
      • Toxicogenomic or Pharmacogenomic Studies
      • PBPK Modeling
      • In vitro to in vivo extrapolation (IVIVE)
      • High Content Imaging
    • Cell Based Assays
      • Cell Cycle Assay
      • Cell Cytotoxicity and Viability
      • Integrated Stress Response Assay
      • Kinetic Proliferation Assay
      • Mitochondrial Fragmentation
    • Organ Specific
      • Liver toxicity
      • Thyroid toxicity
      • Respiratory Toxicity
    • Industries
      • Pharma
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
  • Publications
  • Tools
    • PLETHEM
    • MoAVIZ
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • News
  • Request For Quote

Blog

Featured image for “Why ScitoVation is Part of my Journey”
June 15, 2021

Why ScitoVation is Part of my Journey

Read More
Featured image for “Toward an Actionable Collaborative Data System for Toxicology”
June 9, 2021

Toward an Actionable Collaborative Data System for Toxicology

Read More
Featured image for “Updated Guidance from OECD on Reporting PBPK Models for Risk Assessment”
June 1, 2021

Updated Guidance from OECD on Reporting PBPK Models for Risk Assessment

Read More
Featured image for “Using Cells and Mathematical Models to Interpret Thyroid Hormone Disruption”
May 25, 2021

Using Cells and Mathematical Models to Interpret Thyroid Hormone Disruption

Read More
Featured image for “Using Short-term In Life Transcriptomic Studies to More Effectively Assess Dose Responses and Modes of Action”
May 18, 2021

Using Short-term In Life Transcriptomic Studies to More Effectively Assess Dose Responses and Modes of Action

Read More
Featured image for “Guidelines for assessing Pharmacokinetic Bias in Epidemiology”
May 13, 2021

Guidelines for assessing Pharmacokinetic Bias in Epidemiology

Read More
Featured image for “Better alternative models for risk assessment: In vitro inhalation toxicity assay and dosimetry modeling”
May 5, 2021

Better alternative models for risk assessment: In vitro inhalation toxicity assay and dosimetry modeling

Read More
Featured image for “Water Disinfection: Beneficial or Detrimental?”
January 12, 2021

Water Disinfection: Beneficial or Detrimental?

Read More
Featured image for “What is PBPK Modeling?”
August 25, 2020

What is PBPK Modeling?

Read More
Prev 1 2 3 4 Next
Contact Us

6 Davis Drive, Suite 146,
Durham, NC 27709

© 2022 ScitoVation. Privacy Policy
  • Services
    • Common Problems We Solve
      • Screening and Assessing Lead Compounds
      • Understanding the Mode of Action of a Compound
      • Predicting Equivalent Dose in Humans
    • Technologies
      • Toxicogenomic or Pharmacogenomic Studies
      • PBPK Modeling
      • In vitro to in vivo extrapolation (IVIVE)
      • High Content Imaging
    • Cell Based Assays
      • Cell Cycle Assay
      • Cell Cytotoxicity and Viability
      • Integrated Stress Response Assay
      • Kinetic Proliferation Assay
      • Mitochondrial Fragmentation
    • Organ Specific
      • Liver toxicity
      • Thyroid toxicity
      • Respiratory Toxicity
    • Industries
      • Pharma
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
  • Publications
  • Tools
    • PLETHEM
    • MoAVIZ
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • News
  • Request For Quote